Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-08 Sale |
2022-03-09 4:53 pm |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
1,037 | $70.1 | $72,694 | 55,991 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-09 4:52 pm |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
2,923 | $70.1 | $204,902 | 165,102 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-09 4:51 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
759 | $70.1 | $53,206 | 60,848 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-09 4:50 pm |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
2,339 | $70.1 | $163,964 | 62,462 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-09 4:48 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
2,385 | $70.1 | $167,189 | 552,013 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:28 pm |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
3,067 | $71.87 | $220,414 | 70,907 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:26 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
1,705 | $73.16 | $124,744 | 104,411 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:23 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
5,543 | $72.54 | $402,064 | 133,941 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:18 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
2,313 | $71.83 | $166,136 | 79,131 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:17 pm |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
1,367 | $71.43 | $97,641 | 74,427 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:16 pm |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
3,870 | $71.78 | $277,797 | 214,079 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:14 pm |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
1,485 | $72.97 | $108,359 | 138,394 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:52 pm |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
3,951 | $76 | $300,263 | 56,968 (Direct) |
View |
| 2021-11-26 Purchase |
2021-11-29 4:48 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
4,974 | $102.44 | $509,539 | 13,276 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 4:11 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
209 | $107.28 | $22,421 | 41,758 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:39 pm |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
540 | $138.23 | $74,645 | 87,153 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:37 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
828 | $138.23 | $114,456 | 41,967 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:35 pm |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
181 | $138.23 | $25,020 | 149,899 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:32 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
657 | $138.57 | $91,041 | 73,512 (Direct) |
View |
| 2021-08-12 Sale |
2021-08-16 4:40 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
26,624 | $140.94 | $3,752,286 | 68,477 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:44 pm |
NovoCure Ltd | NVCR | Madden Martin J. Director |
34 | $153.13 | $5,206 | 16,004 (Indirect Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 4:41 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,063 | $148.71 | $306,789 | 74,169 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:39 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $152.5 | $152,500 | 75,204 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:20 pm |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
1,041 | $149.39 | $155,520 | 89,158 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:09 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,654 | $149.43 | $247,157 | 76,232 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:01 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
995 | $149.38 | $148,631 | 554,398 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 4:59 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
464 | $150.11 | $69,651 | 28,144 (Direct) |
View |
| 2021-07-30 Sale |
2021-08-03 5:29 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,187 | $154.63 | $183,550 | 31,861 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-03 Option Award |
2022-03-07 6:28 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
6,106 | $80.59 | 70,907 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:26 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
42,804 | $80.59 | 104,411 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:26 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
21,508 | $0 | 104,411 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:25 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
35,383 | $80.59 | 84,569 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
17,371 | $0 | 84,569 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:23 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
44,258 | $80.59 | 133,941 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:23 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
21,714 | $0 | 133,941 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:22 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
13,470 | $80.59 | 13,470 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:21 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
14,581 | $80.59 | 14,581 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:18 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
35,874 | $80.59 | 79,131 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
17,371 | $0 | 79,131 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:17 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
17,399 | $80.59 | 74,427 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
7,445 | $0 | 74,427 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:16 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
46,054 | $80.59 | 214,079 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:16 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
21,921 | $0 | 214,079 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:14 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
35,355 | $80.59 | 138,394 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:14 pm |
N/A N/A |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
17,371 | $0 | 138,394 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
35 | $63.82 | 31,815 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:39 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
80 | $63.82 | 50,950 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:38 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
55 | $63.82 | 28,199 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:37 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
46 | $63.82 | 41,804 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:31 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
31 | $63.82 | 13,307 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-12 5:30 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
75 | $63.82 | 149,974 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
17,452 | $11.46 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
9,750 | $7.15 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A 2026-02-24 |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
28,604 | $0 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
1,402 | $21.6 | 56,968 (Direct) |
View |
Ownership |
2021-09-03 4:34 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
0 | $0 | 134,931 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
2,606 | $69.37 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
7,298 | $47.04 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A 2025-04-22 |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
36,624 | $0 | 68,477 (Direct) |
View |
| 2021-08-12 Gift |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
1,733 | $0 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
5,927 | $19.25 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
8,026 | $21.5 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
10,000 | $15.6 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
2,767 | $32.02 | 68,477 (Direct) |
View |
| 2021-08-10 Gift |
2021-08-12 4:22 pm |
N/A 2026-01-12 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
640 | $0 | 147,048 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 4:39 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 75,204 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 4:39 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 75,204 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-03 5:29 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
651 | $83.3 | 31,861 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-03 5:29 pm |
N/A 2029-07-30 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
651 | $0 | 31,861 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:38 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
113 | $137.12 | 31,780 (Direct) |
View |